New Zealand: Healthscope to sell NZ pathology business for NZ$550m

Steven Rubic

Private hospital operator Healthscope is to sell its New Zealand pathology business to the NZ Super Fund and Ontario Teachers’ Pension Plan Board for NZ$550m (US$363m). They will each take a 50% stake in the Asia Pacific Healthcare Group (APHG). “The transaction is consistent with our long-term strategic refocus on Healthscope’s Australian hospital operations,” said…

You must be a HMI Subscriber to view this content.

Subscribe Now »